RT Journal Article
SR Electronic
T1 Estimating Burden of Disease among blind individuals with Non-24-Hour Sleep-Wake Disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.11.20061887
DO 10.1101/2020.04.11.20061887
A1 Lauren Van Draanen
A1 Derek Xiao
A1 Mihael H. Polymeropoulos
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.11.20061887.abstract
AB Purpose To quantify the burden of disease in blind patients with Non-24-Hour Sleep-Wake Disorder (N24HSWD), utilizing longitudinal sleep diary data. N24HSWD is a circadian disorder characterized by a cyclical pattern of aberrant circadian and sleep-wake cycles that are associated with increased frequency of sleep episodes during the school/work day hours. Daytime sleep episodes will decrease the opportunity of school/work participation significantly impacting the quality of life of the patient.Methods We used the day time sleep diary data from a period of approximately 90 days in blind individuals with a sleep complaint, which were identified from a group of blind individuals with N24HSWD (n=121) and a control group of blind individuals without N24HSWD (n=57).Results N24HSWD patients had more frequent and longer episodes of daytime sleep as compared to a control group. N24HSWD patients also had significantly fewer healthy days, defined by daytime sleep free days (DSFD), as compared to the control group.Conclusion Daytime sleep free day (DSFD) is a useful and specific measure of disease burden in patients with N24HSWD and it is predicted to be correlated with the standardized HRQOL-4, Healthy Days measurement.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no financial support for the research, authorship, and/or publication of this article.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData analysed during this study are included in this published article